Renal Cancer - Results from #6640

Metabolic syndrome and renal cell carcinoma - Abstract October 15, 2014

The use of sunitinib in renal cell carcinoma: Where are we now? - Abstract October 15, 2014

Partial nephrectomy for the treatment of renal cell carcinoma and the risk of end stage renal disease - Abstract October 14, 2014

Impact of synchronous metastasis distribution on cancer-specific survival in renal cell carcinoma after radical nephrectomy with tumor thrombectomy - Abstract October 14, 2014

Middle segment-preserving pancreatectomy for recurrent metastasis of renal cell carcinoma after pancreatoduodenectomy: A case report - Abstract October 14, 2014

Primary renal neuroblastoma metastasizing into liver and lungs with tumor thrombus extension into the right atrium - Abstract October 14, 2014

Experience with sunitinib treatment for metastatic renal cell carcinoma in a large cohort of Israeli patients: Outcome and associated factors - Abstract October 10, 2014

Prospective non-interventional multicenter observational trial of first-line anti-cancer treatment in patients with metastatic renal cell cancer in Belgium - Abstract October 10, 2014

Indirect comparisons of efficacy and safety between seven newer targeted agents for metastatic renal cell carcinoma: A network meta-analysis of randomised clinical trials - Abstract October 9, 2014

Joint association of genome-wide association study-identified susceptibility Loci and dietary patterns in risk of renal cell carcinoma among non-Hispanic whites - Abstract October 9, 2014

Targeted therapies in advanced renal cell carcinoma: The role of metastatic sites as a prognostic factor - Abstract October 8, 2014

Diffuse bone marrow sarcoid-like reaction associated with renal cell carcinoma - Abstract October 8, 2014

Neoadjuvant sunitinib effectiveness in T4 renal clear cell carcinoma: A case report - Abstract October 7, 2014

Thermal ablation in renal cell carcinoma management: A comprehensive review - Abstract October 7, 2014

Phase II randomized trial comparing sequential first-line everolimus and second-line sunitinib versus first-line sunitinib and second-line everolimus in patients with metastatic renal cell carcinoma - Abstract October 7, 2014

Adjuvant therapy for renal cell carcinoma - Abstract October 7, 2014

Sunitinib, pazopanib or sorafenib for the treatment of patients with late-relapsing (>5 years) metastatic renal cell carcinoma - Abstract October 4, 2014

Impact of adverse events, treatment modifications, and dose intensity on survival among patients with advanced renal cell carcinoma treated with first-line sunitinib: A medical chart review across ten centers in five European countries - Abstract October 3, 2014

Risk evaluation of selective renal arterial embolization in the treatment of delayed hemorrhage from renal artery pseudoaneurysm after partial nephrectomy - Abstract October 2, 2014

Fatigue in patients with advanced renal cell carcinoma receiving sunitinib on an intermittent versus continuous dosing schedule in a randomized phase II trial - Abstract October 2, 2014

Page 333 of 456